Vital capacity reservoir and online measurement of childhood nitrosopnea are linearly related: Clinical implications

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 311-314

  Canady, Robert G ^a   Platts Mills, Thomas ^a   Murphy, Andrew ^a   Johannesen, Roy ^a   Gaston, Benjamin ^a,b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HYPERNITROSOPNEA; INFLAMMATION; PRIORITY JOURNAL; REPRODUCIBILITY; RESPIRATORY TRACT DISEASE; SPIROMETRY; VITAL CAPACITY;

EID: 0032900179     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9803034     Document Type: Article

References (20)

1. Kharitonov, S. A., D. H. Yates, and P. J. Barnes. 1996. Inhaled glucocorticosteroids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153:454-457.
2. Kharitonov, S. A., K. F. Chung, D. J. Evans, B. J. O'Connor, and P. J. Barnes. 1996. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am. J. Respir. Crit. Care Med. 153:1773-1780.
3. Lundberg, J. O. N., S. L. Nordwall, E. Weitzberg, H. Kollberg, and K. Alving. 1996. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch. Dis. Child. 75:323-326.
4. Kanengiser, S., and A. J. Dozor. 1994. Forced expiratory maneuvers in children aged 3 to 5 years. Pediatr. Pulmonol. 18:144-149.
5. Gaston, B., J. Drazen, C. B. E. Chee, M. E. B. Wohl, and J. S. Stamler. 1994. Expired nitric oxide (NO) concentrations are elevated in patients with reactive airways disease. In S. Moncada, M. Feelish, R. Busse, and A. Higgs, editors. Biology of Nitric Oxide: Clinical and Physiological Implications. Portland Press, London. 497-500.
6. Massaro, A. F., B. Gaston, D. Kita, C. Fanta, J. S. Stamler, and J. M. Drazen. 1995. Expired nitric oxide levels during treatment of asthma. Am. J. Respir. Crit. Care Med. 152:800-803.
7. Nelson, B. V., S. Sears, J. Woods, C. Y. Ling, J. Hunt, L. M. Clapper, and B. Gaston. 1997. Expired nitric oxide as a marker for childhood asthma. J. Pediatr. 130:423-427.
8. Baraldi, E., N. M. Azzolin, S. Zanconato, C. Dairo, and F. Zacchello. 1997. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J. Pediatr. 131:381-385.
9. Gaston, B. 1998. Managing asthmatic airway inflammation: what is the role of expired nitric oxide measurement? Curr. Probl. Pediatr. 28:245-252.
10. National Institutes of Health. 1997. Guidelines for the Diagnosis and Management of Asthma: Expert Panel Report 2, July 1997. U.S. Government Printing Office, Washington, DC. NIH Publication No. 97-4051.
11. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. 1997. A Comparison of beclomethasone, salmeterol, and placebo in children with asthma. N. Engl. J. Med. 337:1659-1665.
12. Hamid, Q., D. R. Springall, V. Riveros-Moreno, P. Chanez, P. Howarth, A. Redington, I. Bousquet, P. Godard, S. Holgate, and J. M. Polak. 1993. Induction of nitric oxide synthase in asthma. Lancet 342:1510-1513.
13. Yates, D. H., S. A. Kharitonov, P. S. Thomas, and P. J. Barnes. 1996. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am. J. Respir. Crit. Care Med. 154:247-250.
14. Hunt, J., R. E. Byrns, L. J. Ignarro, and B. Gaston. 1995. Condensed expirate nitrite as a home marker for acute asthma. Lancet 346:1235-1236.
15. Yates, D. H., S. A. Kharitonov, R. A. Robins, P. S. Thomas, and P. J. Barnes. 1995. Effect of nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 152:892-896.
16. Springall, D. R., Q. Meng, A. Redington, P. H. Howarth, T. J. Evans, and J. M. Polak. 1995. Inducible nitric oxide synthase in asthmatic airway epithelium is reduced by corticosteroid therapy (abstract). Am. J. Respir. Crit. Care Med. 151:A833.
17. Gaston, B., S. Sears, J. Woods, J. Hunt, M. Ponaman, T. McMahon, and J. Stamler. 1998. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 351:1317-1319.
18. Lanz, M. J., D. Y. M. Leung, D. R. McCormick, R. Harbeck, S. J. Szefler, and C. W. White. 1997. Comparison of exhaled nitric oxide, serum eosinophilic cationic protein, and soluble interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr. Pulmonol. 24:305-311.
19. Kharitonov, S. A., K. Alving, and P. J. Barnes. 1997. Exhaled and nasal nitric oxide measurements: recommendations. Eur. Respir. J. 10:1683-1693.
20. Silkoff, P. E., P. A. McClean, A. S. Slutsky, H. G. Furlott, E. Hoffstein, S. Wakita, K. R. Chapman, J. P. Szalai, and N. Zamel. 1997. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am. J. Respir. Crit. Care Med. 155:260-267.